Nitrous Oxide Neuroimaging

Last updated: February 3, 2025
Sponsor: Keith M Vogt
Overall Status: Active - Recruiting

Phase

1

Condition

Memory Loss

Memory Problems

Pain

Treatment

Nitrous oxide

Peripheral Nerve Stimulation

Clinical Study ID

NCT06702631
STUDY24100059
R35GM146822
  • Ages 18-59
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to determine the effects of acute pain on long-term memory and conditioned physiologic responses in the presence and absence of low dose nitrous oxide. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will occur over 2 visits and involves no long-term follow up.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • have none of the specific exclusion criteria

  • have a valid email address and valid phone number throughout the study

  • free from any non-MRI compatible implants

Exclusion

Exclusion Criteria:

  • are pregnant or attempting to conceive

  • body mass index (BMI) > 35

  • significant memory impairment or hearing loss

  • sleep apnea

  • chronic pain or frequently taking pain medication (including tramadol)

  • any severe or poorly-controlled medical problem (hypertension, diabetes)

  • neurologic or psychiatric disease, including anxiety, and depression

  • severe cardiac disease

  • history of methylenetetrahydrofolate reductase (MTHFR) deficiency or variantmutation, as assessed by personal report

  • recent ear or eye surgery

  • being claustrophobic

  • have metal implants or non-removable metal piercings

  • having a history of adverse reaction to anesthetics

  • daily alcohol or heavy alcohol use; history of alcohol abuse

  • current daily smoker

  • regular or recent marijuana use (including prescribed/medical marijuana)

  • illicit drug use, i.e., street drugs

  • regularly taking: antiepileptics, antidepressants, anti-psychotics, antihistamines,anti-anxiety medication, stimulants, or sleep-aids

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Nitrous oxide
Phase: 1
Study Start date:
January 13, 2025
Estimated Completion Date:
January 01, 2026

Study Description

This is a non-randomized, clinical trial study of healthy volunteer subjects, which will employ neuroimaging and behavioral measures to characterize the effects of inhalational nitrous oxide on pain processing and cognitive function. Sedative doses of nitrous oxide will be targeted, and steady-state end-tidal (expired) concentrations achieved, while subjects perform a pain and memory cognitive task. At both no-drug baseline and the targeted doses, task and resting-state functional magnetic resonance imaging (MRI) scans will be acquired, and this data will be analyzed subsequently for task-related brain activity (from pain processing and memory formation) and functional connectivity. This work will use a systems neuroscience approach to fill an important knowledge gap about the central effects of inhalational nitrous oxide in the context of painful stimulation.

The investigators propose to complete the following 3 Aims, at a targeted sedative dose of nitrous oxide, compared to no-drug baseline, using functional MRI:

Aim 1: Determine how the brain response to acute pain stimulation is modulated by nitrous oxide. It is anticipated that nitrous oxide will correlate to decreased activation in both somatosensory (thalamus, insula, primary somatosensory/motor) and affective (anterior cingulate) components of the pain processing brain areas.

Aim 2: Determine how memory encoding is modulated by nitrous oxide, in the context of periodic painful stimulation. It is anticipated that nitrous oxide will correlate to decreased activation in both the explicit memory (hippocampus, parahippocampus) and associative learning (amygdala, anterior cingulate) brain systems.

Aim 3: Determine the neural effects of inhalational nitrous oxide on brain connectivity both at rest and during the combined pain and memory task performance. It is anticipated that nitrous oxide will cause widespread dose-dependent decreases in long-range functional connectivity between brain areas known to be involved in pain processing and to the default mode network, and that this connectivity will differ between the resting (task-free) and periodic pain states.

Connect with a study center

  • University of Pittsburgh

    Pittsburgh, Pennsylvania 15213
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.